Evidence map›Paper›PMID 38515127›Full record

ArticleArthritis research & therapy2024

Deficiency of peripheral CLA

Jiachen Li, Feng Sun, Danxue Zhu, Yuke Hou, Gong Cheng, Ping Wang, Xu Jin, Wenyan Zhou, Xiaolin Sun, Zhanguo Li and 1 more

Abstract read
In one paragraph

Article in Arthritis research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Elevated Peripheral CD161ACR open rheumatology · 2026
    Article
  2. Review
  3. [Immunological characteristics of patients with anti-synthetase syndrome overlap with rheumatoid arthritis].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiachen Li *Department of Rheumatology and Immunology, PKUPH, Beijing, 100044, China.
Feng Sun *Department of Rheumatology and Immunology, PKUPH, Beijing, 100044, China.
Danxue ZhuDepartment of Rheumatology and Immunology, PKUPH, Beijing, 100044, China.
Yuke HouDepartment of Rheumatology and Immunology, PKUPH, Beijing, 100044, China.
Gong ChengDepartment of Rheumatology and Immunology, PKUPH, Beijing, 100044, China.
Ping WangDepartment of Rheumatology and Immunology, PKUPH, Beijing, 100044, China.
Xu JinDepartment of Rheumatology and Immunology, PKUPH, Beijing, 100044, China.
Wenyan ZhouDepartment of Rheumatology and Immunology, PKUPH, Beijing, 100044, China.
Xiaolin SunDepartment of Rheumatology and Immunology, PKUPH, Beijing, 100044, China.
Zhanguo LiDepartment of Rheumatology and Immunology, PKUPH, Beijing, 100044, China. li99@bjmu.edu.cn.ORCID 0000-0002-4422-5485
Tian LiuDepartment of Rheumatology and Immunology, PKUPH, Beijing, 100044, China. mikle317@163.com.ORCID 0000-0002-1691-8372

Funding

This study was supported by Bethune-Puai Medical Research Fund PAYJ-023
6 · The paper itself

Abstract

backgroundAutoimmune responses have been suggested to involvement in patients with Behcet's syndrome (BS). There has been growing attention towards the roles of cutaneous lymphocyte antigen (CLA)

methodsWe collected peripheral blood from a total of 107 patients with BS and 114 healthy controls (HCs). The number of CLA

resultsThe absolute number and proportion of CLA

conclusionCLA

Indexed as

AneurysmBehcet SyndromeClinical RelevanceHumansOligosaccharidesSialyl Lewis X AntigenT-Lymphocytes, Regulatory6-sulfo sialyl Lewis XOligosaccharidesSialyl Lewis X AntigenArterial aneurysmsBehcet’s syndromeCLA+ TregsFlow cytometry

Identifiers

PMID38515127
PMCPMC10956224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.